<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE,BoldItalic" color="#000000"/>
	<fontspec id="font6" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font7" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font8" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font9" size="9" family="Symbol" color="#000000"/>
	<fontspec id="font10" size="8" family="AkzidenzGroteskBE,BoldItalic" color="#000000"/>
	<fontspec id="font11" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
<text top="42" left="306" width="250" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="text">Available online http://breast-cancer-research.com/content/7/6/R1028<b>Available online</b></text>
<text top="735" left="569" width="23" height="8" font="font3" id="p1_t2" reading_order_no="191" segment_no="8" tag_type="text">R1030</text>
<text top="549" left="57" width="203" height="8" font="font4" id="p1_t3" reading_order_no="161" segment_no="5" tag_type="title">Immunohistochemical and chromogenic in situ</text>
<text top="561" left="57" width="94" height="8" font="font4" id="p1_t4" reading_order_no="162" segment_no="5" tag_type="title">hybridization analysis<b>Immunohistochemical and chromogenic </b></text>
<text top="573" left="57" width="240" height="9" font="font6" id="p1_t5" reading_order_no="163" segment_no="7" tag_type="text">Immunohistochemistry was performed with antibodies raised<i><b>in situ </b></i></text>
<text top="584" left="57" width="240" height="9" font="font6" id="p1_t6" reading_order_no="164" segment_no="7" tag_type="text">against HER2 (Herceptest ® (Dako, Glosatrup, Denmark), pol-<b>hybridization analysis</b></text>
<text top="596" left="57" width="240" height="9" font="font6" id="p1_t7" reading_order_no="165" segment_no="7" tag_type="text">yclonal, 1/10 epitope retrieval solution (Dako) at 98°C, predi-</text>
<text top="608" left="57" width="240" height="9" font="font6" id="p1_t8" reading_order_no="166" segment_no="7" tag_type="text">luted; and CB11 (Novocastra, Newcastle-upon-Tyne, UK), 2</text>
<text top="620" left="57" width="240" height="9" font="font6" id="p1_t9" reading_order_no="167" segment_no="7" tag_type="text">min in a pressure cooker, 1:100) and EGFR (31G7, 1:50,</text>
<text top="631" left="57" width="240" height="9" font="font6" id="p1_t10" reading_order_no="168" segment_no="7" tag_type="text">Zymed (South San Francisco, CA, USA)), as previously</text>
<text top="643" left="57" width="240" height="9" font="font6" id="p1_t11" reading_order_no="169" segment_no="7" tag_type="text">described [34]. For Her2/neu and EGFR, the Herceptest ®</text>
<text top="655" left="57" width="240" height="9" font="font6" id="p1_t12" reading_order_no="170" segment_no="7" tag_type="text">scoring system was applied: negative = no membrane staining</text>
<text top="667" left="57" width="240" height="9" font="font6" id="p1_t13" reading_order_no="171" segment_no="7" tag_type="text">or &lt;10% of cells stained; 1+ = incomplete membrane staining</text>
<text top="678" left="57" width="240" height="9" font="font6" id="p1_t14" reading_order_no="172" segment_no="7" tag_type="text">in &gt;10% of cells; 2+ = &gt;10% of cells with weak to moderate</text>
<text top="690" left="57" width="240" height="9" font="font6" id="p1_t15" reading_order_no="173" segment_no="7" tag_type="text">complete membrane staining; and 3+ = strong and complete<a href="">ribed [34]. </a>For Her2/neu and EGFR, the Herceptest</text>
<text top="702" left="57" width="144" height="9" font="font6" id="p1_t16" reading_order_no="174" segment_no="7" tag_type="text">membrane staining in &gt;10% of cells.</text>
<text top="549" left="315" width="240" height="9" font="font6" id="p1_t17" reading_order_no="175" segment_no="6" tag_type="text">CISH was performed using Spot-Light amplification probes</text>
<text top="561" left="315" width="241" height="9" font="font6" id="p1_t18" reading_order_no="176" segment_no="6" tag_type="text">for EGFR (Zymed) and HER2 (Zymed), in accordance with the</text>
<text top="573" left="315" width="240" height="9" font="font6" id="p1_t19" reading_order_no="177" segment_no="6" tag_type="text">manufacturer protocol and as previously described [34].</text>
<text top="584" left="315" width="240" height="9" font="font6" id="p1_t20" reading_order_no="178" segment_no="6" tag_type="text">Because the interpretation guidelines for Spot-Light EGFR</text>
<text top="596" left="315" width="241" height="9" font="font6" id="p1_t21" reading_order_no="179" segment_no="6" tag_type="text">and HER2 amplification probes have previously been vali-</text>
<text top="606" left="315" width="240" height="12" font="font6" id="p1_t22" reading_order_no="180" segment_no="6" tag_type="text">dated [8,34,35], we did not use α -satellite probes for chromo-</text>
<text top="620" left="315" width="241" height="9" font="font6" id="p1_t23" reading_order_no="181" segment_no="6" tag_type="text">somes 7 and 17, respectively. All cases were subjected to</text>
<text top="631" left="315" width="241" height="9" font="font6" id="p1_t24" reading_order_no="182" segment_no="6" tag_type="text">CISH for EGFR , and only those with HER2 grade 2+ or 3+<i>EGFR</i></text>
<text top="643" left="315" width="241" height="9" font="font6" id="p1_t25" reading_order_no="183" segment_no="6" tag_type="text">positivity were subjected to CISH for HER2 [36]. Appropriate</text>
<text top="655" left="315" width="240" height="9" font="font6" id="p1_t26" reading_order_no="184" segment_no="6" tag_type="text">gene amplified breast tumour controls were included in each<i>HER2</i></text>
<text top="667" left="315" width="240" height="9" font="font6" id="p1_t27" reading_order_no="185" segment_no="6" tag_type="text">run. Each section was analyzed by two of the authors (FM and</text>
<text top="678" left="315" width="240" height="9" font="font6" id="p1_t28" reading_order_no="186" segment_no="6" tag_type="text">SC) on a multiheaded microscope. Only unequivocal signals<a href="">ribed [34].</a></text>
<text top="690" left="315" width="240" height="9" font="font6" id="p1_t29" reading_order_no="187" segment_no="6" tag_type="text">were counted. Signals were evaluated at 400× and 630×, and</text>
<text top="702" left="315" width="240" height="9" font="font6" id="p1_t30" reading_order_no="188" segment_no="6" tag_type="text">at least 60 cells were evaluated for the presence of the EGFR<i>EGFR</i></text>
<text top="714" left="315" width="240" height="9" font="font6" id="p1_t31" reading_order_no="189" segment_no="6" tag_type="text">probe. A given tumour was considered to be amplified for</text>
<text top="725" left="315" width="241" height="9" font="font8" id="p1_t32" reading_order_no="190" segment_no="6" tag_type="text">EGFR or HER2 when more than 50% of the neoplastic cells<i>HER2</i></text>
<text top="85" left="57" width="28" height="7" font="font0" id="p1_t33" reading_order_no="1" segment_no="1" tag_type="title">Table 1</text>
<text top="104" left="57" width="361" height="7" font="font0" id="p1_t34" reading_order_no="2" segment_no="2" tag_type="text">Summary of histological, immunohistochemical and chromogenic in situ hybridization findings<a href="">dated [8,34,35</a>], we did not use </text>
<text top="123" left="61" width="18" height="7" font="font2" id="p1_t35" reading_order_no="3" segment_no="3" tag_type="table">Case</text>
<text top="123" left="93" width="57" height="7" font="font2" id="p1_t36" reading_order_no="4" segment_no="3" tag_type="table">Histological type</text>
<text top="122" left="271" width="70" height="8" font="font2" id="p1_t37" reading_order_no="5" segment_no="3" tag_type="table">HER2 (Herceptest ® )</text>
<text top="123" left="366" width="49" height="7" font="font2" id="p1_t38" reading_order_no="6" segment_no="3" tag_type="table">HER2 (CB11)</text>
<text top="123" left="435" width="42" height="7" font="font2" id="p1_t39" reading_order_no="7" segment_no="3" tag_type="table">EGFR (IHC)<i>EGFR</i></text>
<text top="123" left="498" width="47" height="7" font="font11" id="p1_t40" reading_order_no="8" segment_no="3" tag_type="table">EGFR (CISH)</text>
<text top="139" left="61" width="5" height="7" font="font2" id="p1_t41" reading_order_no="68" segment_no="3" tag_type="table">1</text>
<text top="139" left="93" width="129" height="7" font="font2" id="p1_t42" reading_order_no="9" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia<i>HER2</i></text>
<text top="139" left="305" width="2" height="7" font="font2" id="p1_t43" reading_order_no="10" segment_no="3" tag_type="table">-<a href="">[36]</a>. Appropriate</text>
<text top="139" left="389" width="2" height="7" font="font2" id="p1_t44" reading_order_no="11" segment_no="3" tag_type="table">-</text>
<text top="139" left="451" width="10" height="7" font="font2" id="p1_t45" reading_order_no="12" segment_no="3" tag_type="table">3+</text>
<text top="139" left="508" width="27" height="7" font="font2" id="p1_t46" reading_order_no="13" segment_no="3" tag_type="table">No amp</text>
<text top="154" left="61" width="5" height="7" font="font2" id="p1_t47" reading_order_no="14" segment_no="3" tag_type="table">2</text>
<text top="154" left="93" width="129" height="7" font="font2" id="p1_t48" reading_order_no="15" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia</text>
<text top="154" left="305" width="2" height="7" font="font2" id="p1_t49" reading_order_no="16" segment_no="3" tag_type="table">-<i>EGFR</i></text>
<text top="154" left="389" width="2" height="7" font="font2" id="p1_t50" reading_order_no="17" segment_no="3" tag_type="table">-</text>
<text top="154" left="451" width="10" height="7" font="font2" id="p1_t51" reading_order_no="18" segment_no="3" tag_type="table">3+<i>EGFR</i></text>
<text top="154" left="508" width="27" height="7" font="font2" id="p1_t52" reading_order_no="19" segment_no="3" tag_type="table">No amp</text>
<text top="170" left="61" width="5" height="7" font="font2" id="p1_t53" reading_order_no="81" segment_no="3" tag_type="table">3<i>HER2</i></text>
<text top="170" left="93" width="129" height="7" font="font2" id="p1_t54" reading_order_no="20" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia</text>
<text top="170" left="305" width="2" height="7" font="font2" id="p1_t55" reading_order_no="21" segment_no="3" tag_type="table">-<b>Table 1</b></text>
<text top="170" left="389" width="2" height="7" font="font2" id="p1_t56" reading_order_no="22" segment_no="3" tag_type="table">-<b>Summary of histological, immunohistochemical and chromogenic </b></text>
<text top="170" left="451" width="10" height="7" font="font2" id="p1_t57" reading_order_no="23" segment_no="3" tag_type="table">3+<i><b>in situ </b></i></text>
<text top="170" left="508" width="27" height="7" font="font2" id="p1_t58" reading_order_no="24" segment_no="3" tag_type="table">No amp<b>hybridization findings</b></text>
<text top="185" left="61" width="5" height="7" font="font2" id="p1_t59" reading_order_no="88" segment_no="3" tag_type="table">4</text>
<text top="185" left="93" width="129" height="7" font="font2" id="p1_t60" reading_order_no="25" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia</text>
<text top="185" left="305" width="2" height="7" font="font2" id="p1_t61" reading_order_no="26" segment_no="3" tag_type="table">-</text>
<text top="185" left="389" width="2" height="7" font="font2" id="p1_t62" reading_order_no="27" segment_no="3" tag_type="table">-</text>
<text top="185" left="451" width="10" height="7" font="font2" id="p1_t63" reading_order_no="28" segment_no="3" tag_type="table">3+</text>
<text top="185" left="508" width="27" height="7" font="font2" id="p1_t64" reading_order_no="29" segment_no="3" tag_type="table">No amp</text>
<text top="201" left="61" width="5" height="7" font="font2" id="p1_t65" reading_order_no="95" segment_no="3" tag_type="table">5</text>
<text top="201" left="93" width="129" height="7" font="font2" id="p1_t66" reading_order_no="30" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia<i>EGFR</i></text>
<text top="201" left="305" width="2" height="7" font="font2" id="p1_t67" reading_order_no="31" segment_no="3" tag_type="table">-</text>
<text top="201" left="389" width="2" height="7" font="font2" id="p1_t68" reading_order_no="32" segment_no="3" tag_type="table">-</text>
<text top="201" left="451" width="10" height="7" font="font2" id="p1_t69" reading_order_no="33" segment_no="3" tag_type="table">3+</text>
<text top="201" left="513" width="16" height="7" font="font2" id="p1_t70" reading_order_no="34" segment_no="3" tag_type="table">Amp</text>
<text top="216" left="61" width="5" height="7" font="font2" id="p1_t71" reading_order_no="102" segment_no="3" tag_type="table">6</text>
<text top="216" left="93" width="129" height="7" font="font2" id="p1_t72" reading_order_no="35" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia</text>
<text top="216" left="305" width="2" height="7" font="font2" id="p1_t73" reading_order_no="36" segment_no="3" tag_type="table">-</text>
<text top="216" left="389" width="2" height="7" font="font2" id="p1_t74" reading_order_no="37" segment_no="3" tag_type="table">-</text>
<text top="216" left="451" width="10" height="7" font="font2" id="p1_t75" reading_order_no="38" segment_no="3" tag_type="table">3+</text>
<text top="216" left="513" width="16" height="7" font="font2" id="p1_t76" reading_order_no="39" segment_no="3" tag_type="table">Amp</text>
<text top="232" left="61" width="5" height="7" font="font2" id="p1_t77" reading_order_no="40" segment_no="3" tag_type="table">7</text>
<text top="232" left="93" width="129" height="7" font="font2" id="p1_t78" reading_order_no="41" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia</text>
<text top="232" left="301" width="10" height="7" font="font2" id="p1_t79" reading_order_no="42" segment_no="3" tag_type="table">1+</text>
<text top="232" left="389" width="2" height="7" font="font2" id="p1_t80" reading_order_no="43" segment_no="3" tag_type="table">-</text>
<text top="232" left="451" width="10" height="7" font="font2" id="p1_t81" reading_order_no="44" segment_no="3" tag_type="table">3+</text>
<text top="232" left="508" width="27" height="7" font="font2" id="p1_t82" reading_order_no="45" segment_no="3" tag_type="table">No amp</text>
<text top="247" left="61" width="5" height="7" font="font2" id="p1_t83" reading_order_no="115" segment_no="3" tag_type="table">8</text>
<text top="247" left="93" width="129" height="7" font="font2" id="p1_t84" reading_order_no="46" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia</text>
<text top="247" left="305" width="2" height="7" font="font2" id="p1_t85" reading_order_no="47" segment_no="3" tag_type="table">-</text>
<text top="247" left="389" width="2" height="7" font="font2" id="p1_t86" reading_order_no="48" segment_no="3" tag_type="table">-</text>
<text top="247" left="451" width="10" height="7" font="font2" id="p1_t87" reading_order_no="49" segment_no="3" tag_type="table">3+</text>
<text top="247" left="513" width="16" height="7" font="font2" id="p1_t88" reading_order_no="50" segment_no="3" tag_type="table">Amp</text>
<text top="263" left="61" width="5" height="7" font="font2" id="p1_t89" reading_order_no="51" segment_no="3" tag_type="table">9</text>
<text top="263" left="93" width="129" height="7" font="font2" id="p1_t90" reading_order_no="52" segment_no="3" tag_type="table">Carcinoma with squamous metaplasia</text>
<text top="263" left="305" width="2" height="7" font="font2" id="p1_t91" reading_order_no="53" segment_no="3" tag_type="table">-</text>
<text top="263" left="389" width="2" height="7" font="font2" id="p1_t92" reading_order_no="54" segment_no="3" tag_type="table">-</text>
<text top="263" left="451" width="10" height="7" font="font2" id="p1_t93" reading_order_no="55" segment_no="3" tag_type="table">1+</text>
<text top="263" left="508" width="27" height="7" font="font2" id="p1_t94" reading_order_no="56" segment_no="3" tag_type="table">No amp</text>
<text top="278" left="61" width="9" height="7" font="font2" id="p1_t95" reading_order_no="57" segment_no="3" tag_type="table">10</text>
<text top="278" left="93" width="77" height="7" font="font2" id="p1_t96" reading_order_no="58" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="278" left="305" width="2" height="7" font="font2" id="p1_t97" reading_order_no="59" segment_no="3" tag_type="table">-</text>
<text top="278" left="389" width="2" height="7" font="font2" id="p1_t98" reading_order_no="60" segment_no="3" tag_type="table">-</text>
<text top="278" left="451" width="10" height="7" font="font2" id="p1_t99" reading_order_no="61" segment_no="3" tag_type="table">3+</text>
<text top="278" left="508" width="27" height="7" font="font2" id="p1_t100" reading_order_no="62" segment_no="3" tag_type="table">No amp</text>
<text top="294" left="61" width="9" height="7" font="font2" id="p1_t101" reading_order_no="63" segment_no="3" tag_type="table">11</text>
<text top="294" left="93" width="77" height="7" font="font2" id="p1_t102" reading_order_no="64" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="294" left="305" width="2" height="7" font="font2" id="p1_t103" reading_order_no="65" segment_no="3" tag_type="table">-</text>
<text top="294" left="389" width="2" height="7" font="font2" id="p1_t104" reading_order_no="66" segment_no="3" tag_type="table">-</text>
<text top="294" left="451" width="10" height="7" font="font2" id="p1_t105" reading_order_no="67" segment_no="3" tag_type="table">3+</text>
<text top="294" left="508" width="27" height="7" font="font2" id="p1_t106" reading_order_no="69" segment_no="3" tag_type="table">No amp</text>
<text top="309" left="61" width="9" height="7" font="font2" id="p1_t107" reading_order_no="70" segment_no="3" tag_type="table">12</text>
<text top="309" left="93" width="77" height="7" font="font2" id="p1_t108" reading_order_no="71" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="309" left="305" width="2" height="7" font="font2" id="p1_t109" reading_order_no="72" segment_no="3" tag_type="table">-</text>
<text top="309" left="389" width="2" height="7" font="font2" id="p1_t110" reading_order_no="73" segment_no="3" tag_type="table">-</text>
<text top="309" left="451" width="10" height="7" font="font2" id="p1_t111" reading_order_no="74" segment_no="3" tag_type="table">1+</text>
<text top="309" left="508" width="27" height="7" font="font2" id="p1_t112" reading_order_no="75" segment_no="3" tag_type="table">No amp</text>
<text top="325" left="61" width="9" height="7" font="font2" id="p1_t113" reading_order_no="76" segment_no="3" tag_type="table">13</text>
<text top="325" left="93" width="77" height="7" font="font2" id="p1_t114" reading_order_no="77" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="325" left="305" width="2" height="7" font="font2" id="p1_t115" reading_order_no="78" segment_no="3" tag_type="table">-</text>
<text top="325" left="389" width="2" height="7" font="font2" id="p1_t116" reading_order_no="79" segment_no="3" tag_type="table">-</text>
<text top="325" left="451" width="10" height="7" font="font2" id="p1_t117" reading_order_no="80" segment_no="3" tag_type="table">3+</text>
<text top="325" left="513" width="16" height="7" font="font2" id="p1_t118" reading_order_no="82" segment_no="3" tag_type="table">Amp</text>
<text top="340" left="61" width="9" height="7" font="font2" id="p1_t119" reading_order_no="83" segment_no="3" tag_type="table">14</text>
<text top="340" left="93" width="77" height="7" font="font2" id="p1_t120" reading_order_no="84" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="340" left="305" width="2" height="7" font="font2" id="p1_t121" reading_order_no="85" segment_no="3" tag_type="table">-</text>
<text top="340" left="389" width="2" height="7" font="font2" id="p1_t122" reading_order_no="86" segment_no="3" tag_type="table">-</text>
<text top="340" left="455" width="2" height="7" font="font2" id="p1_t123" reading_order_no="87" segment_no="3" tag_type="table">-</text>
<text top="340" left="508" width="27" height="7" font="font2" id="p1_t124" reading_order_no="89" segment_no="3" tag_type="table">No amp</text>
<text top="356" left="61" width="9" height="7" font="font2" id="p1_t125" reading_order_no="90" segment_no="3" tag_type="table">15</text>
<text top="356" left="93" width="77" height="7" font="font2" id="p1_t126" reading_order_no="91" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="356" left="305" width="2" height="7" font="font2" id="p1_t127" reading_order_no="92" segment_no="3" tag_type="table">-</text>
<text top="356" left="389" width="2" height="7" font="font2" id="p1_t128" reading_order_no="93" segment_no="3" tag_type="table">-</text>
<text top="356" left="451" width="10" height="7" font="font2" id="p1_t129" reading_order_no="94" segment_no="3" tag_type="table">3+</text>
<text top="356" left="513" width="16" height="7" font="font2" id="p1_t130" reading_order_no="96" segment_no="3" tag_type="table">Amp</text>
<text top="371" left="61" width="9" height="7" font="font2" id="p1_t131" reading_order_no="97" segment_no="3" tag_type="table">16</text>
<text top="371" left="93" width="77" height="7" font="font2" id="p1_t132" reading_order_no="98" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="371" left="305" width="2" height="7" font="font2" id="p1_t133" reading_order_no="99" segment_no="3" tag_type="table">-</text>
<text top="371" left="389" width="2" height="7" font="font2" id="p1_t134" reading_order_no="100" segment_no="3" tag_type="table">-</text>
<text top="371" left="455" width="2" height="7" font="font2" id="p1_t135" reading_order_no="101" segment_no="3" tag_type="table">-</text>
<text top="371" left="508" width="27" height="7" font="font2" id="p1_t136" reading_order_no="103" segment_no="3" tag_type="table">No amp</text>
<text top="387" left="61" width="9" height="7" font="font2" id="p1_t137" reading_order_no="104" segment_no="3" tag_type="table">17</text>
<text top="387" left="93" width="77" height="7" font="font2" id="p1_t138" reading_order_no="105" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="387" left="305" width="2" height="7" font="font2" id="p1_t139" reading_order_no="106" segment_no="3" tag_type="table">-</text>
<text top="387" left="389" width="2" height="7" font="font2" id="p1_t140" reading_order_no="107" segment_no="3" tag_type="table">-</text>
<text top="387" left="451" width="10" height="7" font="font2" id="p1_t141" reading_order_no="108" segment_no="3" tag_type="table">3+</text>
<text top="387" left="513" width="16" height="7" font="font2" id="p1_t142" reading_order_no="109" segment_no="3" tag_type="table">Amp</text>
<text top="402" left="61" width="9" height="7" font="font2" id="p1_t143" reading_order_no="110" segment_no="3" tag_type="table">18</text>
<text top="402" left="93" width="77" height="7" font="font2" id="p1_t144" reading_order_no="111" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="402" left="305" width="2" height="7" font="font2" id="p1_t145" reading_order_no="112" segment_no="3" tag_type="table">-</text>
<text top="402" left="389" width="2" height="7" font="font2" id="p1_t146" reading_order_no="113" segment_no="3" tag_type="table">-</text>
<text top="402" left="451" width="10" height="7" font="font2" id="p1_t147" reading_order_no="114" segment_no="3" tag_type="table">3+</text>
<text top="402" left="508" width="27" height="7" font="font2" id="p1_t148" reading_order_no="116" segment_no="3" tag_type="table">No amp</text>
<text top="418" left="61" width="9" height="7" font="font2" id="p1_t149" reading_order_no="117" segment_no="3" tag_type="table">19</text>
<text top="418" left="93" width="77" height="7" font="font2" id="p1_t150" reading_order_no="118" segment_no="3" tag_type="table">Spindle cell carcinoma</text>
<text top="418" left="300" width="13" height="7" font="font2" id="p1_t151" reading_order_no="119" segment_no="3" tag_type="table">2+ a</text>
<text top="418" left="384" width="13" height="7" font="font2" id="p1_t152" reading_order_no="120" segment_no="3" tag_type="table">1+ a</text>
<text top="418" left="451" width="10" height="7" font="font2" id="p1_t153" reading_order_no="121" segment_no="3" tag_type="table">3+</text>
<text top="418" left="513" width="16" height="7" font="font2" id="p1_t154" reading_order_no="122" segment_no="3" tag_type="table">Amp</text>
<text top="433" left="61" width="9" height="7" font="font2" id="p1_t155" reading_order_no="123" segment_no="3" tag_type="table">20</text>
<text top="433" left="93" width="133" height="7" font="font2" id="p1_t156" reading_order_no="124" segment_no="3" tag_type="table">Carcinoma with heterologous elements</text>
<text top="433" left="305" width="2" height="7" font="font2" id="p1_t157" reading_order_no="125" segment_no="3" tag_type="table">-</text>
<text top="433" left="389" width="2" height="7" font="font2" id="p1_t158" reading_order_no="126" segment_no="3" tag_type="table">-</text>
<text top="433" left="451" width="10" height="7" font="font2" id="p1_t159" reading_order_no="127" segment_no="3" tag_type="table">3+</text>
<text top="433" left="508" width="27" height="7" font="font2" id="p1_t160" reading_order_no="128" segment_no="3" tag_type="table">No amp</text>
<text top="449" left="61" width="9" height="7" font="font2" id="p1_t161" reading_order_no="129" segment_no="3" tag_type="table">21</text>
<text top="449" left="93" width="133" height="7" font="font2" id="p1_t162" reading_order_no="130" segment_no="3" tag_type="table">Carcinoma with heterologous elements</text>
<text top="449" left="305" width="2" height="7" font="font2" id="p1_t163" reading_order_no="131" segment_no="3" tag_type="table">-</text>
<text top="449" left="389" width="2" height="7" font="font2" id="p1_t164" reading_order_no="132" segment_no="3" tag_type="table">-</text>
<text top="449" left="451" width="10" height="7" font="font2" id="p1_t165" reading_order_no="133" segment_no="3" tag_type="table">3+</text>
<text top="449" left="508" width="27" height="7" font="font2" id="p1_t166" reading_order_no="134" segment_no="3" tag_type="table">No amp</text>
<text top="464" left="61" width="9" height="7" font="font2" id="p1_t167" reading_order_no="135" segment_no="3" tag_type="table">22</text>
<text top="464" left="93" width="94" height="7" font="font2" id="p1_t168" reading_order_no="136" segment_no="3" tag_type="table">Matrix producing carcinoma</text>
<text top="464" left="305" width="2" height="7" font="font2" id="p1_t169" reading_order_no="137" segment_no="3" tag_type="table">-</text>
<text top="464" left="389" width="2" height="7" font="font2" id="p1_t170" reading_order_no="138" segment_no="3" tag_type="table">-</text>
<text top="464" left="451" width="10" height="7" font="font2" id="p1_t171" reading_order_no="139" segment_no="3" tag_type="table">1+</text>
<text top="464" left="508" width="27" height="7" font="font2" id="p1_t172" reading_order_no="140" segment_no="3" tag_type="table">No amp</text>
<text top="480" left="61" width="9" height="7" font="font2" id="p1_t173" reading_order_no="141" segment_no="3" tag_type="table">23</text>
<text top="480" left="93" width="94" height="7" font="font2" id="p1_t174" reading_order_no="142" segment_no="3" tag_type="table">Matrix producing carcinoma</text>
<text top="480" left="305" width="2" height="7" font="font2" id="p1_t175" reading_order_no="143" segment_no="3" tag_type="table">-</text>
<text top="480" left="389" width="2" height="7" font="font2" id="p1_t176" reading_order_no="144" segment_no="3" tag_type="table">-</text>
<text top="480" left="455" width="2" height="7" font="font2" id="p1_t177" reading_order_no="145" segment_no="3" tag_type="table">-</text>
<text top="480" left="508" width="27" height="7" font="font2" id="p1_t178" reading_order_no="146" segment_no="3" tag_type="table">No amp</text>
<text top="495" left="61" width="9" height="7" font="font2" id="p1_t179" reading_order_no="147" segment_no="3" tag_type="table">24</text>
<text top="495" left="93" width="94" height="7" font="font2" id="p1_t180" reading_order_no="148" segment_no="3" tag_type="table">Matrix producing carcinoma</text>
<text top="495" left="305" width="2" height="7" font="font2" id="p1_t181" reading_order_no="149" segment_no="3" tag_type="table">-</text>
<text top="495" left="389" width="2" height="7" font="font2" id="p1_t182" reading_order_no="150" segment_no="3" tag_type="table">-</text>
<text top="495" left="451" width="10" height="7" font="font2" id="p1_t183" reading_order_no="151" segment_no="3" tag_type="table">3+</text>
<text top="495" left="508" width="27" height="7" font="font2" id="p1_t184" reading_order_no="152" segment_no="3" tag_type="table">No amp</text>
<text top="511" left="61" width="9" height="7" font="font2" id="p1_t185" reading_order_no="153" segment_no="3" tag_type="table">25</text>
<text top="511" left="93" width="94" height="7" font="font2" id="p1_t186" reading_order_no="154" segment_no="3" tag_type="table">Matrix producing carcinoma</text>
<text top="511" left="305" width="2" height="7" font="font2" id="p1_t187" reading_order_no="155" segment_no="3" tag_type="table">-</text>
<text top="511" left="389" width="2" height="7" font="font2" id="p1_t188" reading_order_no="156" segment_no="3" tag_type="table">-</text>
<text top="511" left="451" width="10" height="7" font="font2" id="p1_t189" reading_order_no="157" segment_no="3" tag_type="table">3+</text>
<text top="511" left="508" width="27" height="7" font="font2" id="p1_t190" reading_order_no="158" segment_no="3" tag_type="table">No amp</text>
<text top="527" left="61" width="475" height="7" font="font2" id="p1_t191" reading_order_no="159" segment_no="4" tag_type="text">a No HER2 gene amplification was detected by CISH. Amp, amplification; CISH, chromogenic in situ hybridization; EGFR, epidermal growth</text>
<text top="535" left="61" width="286" height="7" font="font2" id="p1_t192" reading_order_no="160" segment_no="4" tag_type="text">factor receptor; HER, epidermal growth factor receptor; IHC, immunohistochemistry.</text>
</page>
</pdf2xml>
